Individual provider · Type 1 NPI
Jacob Barker, PharmD
Oncology Pharmacist · Burlington, VT
NPI number
1669340220
Active
Practice location
111 Colchester Ave
Burlington, VT 05401-1473
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Oncology Pharmacist Primary | 1835X0200X | 033.0134097 (VT) |
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
1,528 other providers at this address
- Fletcher Allen Health CareChildren's Hospital Burlington, VT NPI 1356458087
- Fletcher Allen Health CareWomen's Hospital Burlington, VT NPI 1447278965
- Fletcher Allen Health Care IncRadiation Oncology Physician Burlington, VT NPI 1619266624
- Fletcher Allen Health Care Specialty Services, LLCInternal Medicine Physician Burlington, VT NPI 1346682093
- Fletcher Allen Health Care Specialty Services, LLCAnesthesiology Physician Burlington, VT NPI 1801228697
- Fletcher Allen Health Care, IncPharmacy Burlington, VT NPI 1447596788
- Radiation Medicine Affiliates, IncRadiation Oncology Physician Burlington, VT NPI 1285655332
- University of Vermont Health Network Specialty Care Transport, LLCLand Ambulance Burlington, VT NPI 1164466439
- University of Vermont Medical CenterClinic/Center Burlington, VT NPI 1932353737
- University of Vermont Medical Center IncHematology (Internal Medicine) Physician Burlington, VT NPI 1083904213
- University of Vermont Medical Center IncDurable Medical Equipment & Medical Supplies Burlington, VT NPI 1245316918
- University of Vermont Medical Center IncEnd-Stage Renal Disease (ESRD) Treatment Clinic/Center Burlington, VT NPI 1508808353
About NPI 1669340220
Jacob Barker, PharmD's National Provider Identifier is 1669340220, issued on Oct 27, 2025. The primary taxonomy on file is Oncology Pharmacist (1835X0200X), and the practice location is in Burlington, VT. The record was last updated on Oct 27, 2025.